ORKA files notice to sell 35,000 common shares

ORKA filed a notice of proposed sale of 35,000 shares of Common Stock.

Rhea-AI Filing Summary

ORKA filed a notice of proposed sale of 35,000 shares of Common Stock. The filing identifies Morgan Stanley Smith Barney LLC as the broker and lists a 02/14/2024 partnership distribution of 35,000 shares for cash. The excerpt also records a prior 10b5-1 sale by Carl Dambkowski of 105,000 shares on 05/21/2026 for $6,191,367.00.

Insights

Securities Compliance Counsel

Routine Rule 144 notice listing a proposed sale and a recent 10b5-1 disposition.

The filing lists a proposed sale of 35,000 shares of Common Stock through Morgan Stanley Smith Barney LLC, with a referenced 02/14/2024 partnership distribution of 35,000 shares for cash. It separately documents a completed 10b5-1 sale by Carl Dambkowski of 105,000 shares on 05/21/2026 for $6,191,367.00.

These items are routine regulatory notices. The practical effect depends on whether the proposed sale is executed and on any transfer restrictions; timing and cash-flow treatment for the proposed sale are not specified in the excerpt.

Key Figures

Proposed sale: 35,000 shares Reported insider sale: 105,000 shares Consideration reported for insider sale: $6,191,367.00

3 metrics

Proposed sale 35,000 shares Common Stock proposed sale listed in the notice

Reported insider sale 105,000 shares Carl Dambkowski 10b5-1 sale on <date>05/21/2026</date>

Consideration reported for insider sale $6,191,367.00 Proceeds listed for the 10b5-1 sale on <date>05/21/2026</date>

Key Terms

10b5-1, Partnership Distribution, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CARL DAMBKOWSKI 855 Oak Grove Avenue Suite 100"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Partnership Distribution financial

"Common | 02/14/2024 | Partnership Distribution | Issuer"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ORKA's Form 144 report about the proposed sale?

It reports a proposed sale of 35,000 shares of Common Stock through Morgan Stanley Smith Barney LLC. The filing cites a 02/14/2024 partnership distribution of 35,000 shares for cash and lists broker details.

Did any insider complete a sale reported in the excerpt for ORKA?

Yes. The excerpt records a 10b5-1 sale by Carl Dambkowski of 105,000 shares on 05/21/2026 for $6,191,367.00. This is presented as a completed disposition in the excerpt.

Who is the broker handling the proposed sale in ORKA's filing?

The broker named is Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY. The excerpt pairs that broker with the 35,000 shares proposed sale entry.

Does the excerpt state proceeds or timing for the proposed 35,000-share sale?

The excerpt lists a 02/14/2024 partnership distribution and labels the consideration as cash, but it does not specify execution timing or net proceeds for the currently proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:24 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001983476
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oruka Therapeutics, Inc.
SEC File Number	000-22873
Address of Issuer	855 Oak Grove Avenue Suite 100 Menlo Park CALIFORNIA 94025
Phone	6506067910
Name of Person for Whose Account the Securities are To Be Sold	CARL DAMBKOWSKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	35000	2241050.00	60312101	06/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2024	Partnership Distribution	Issuer			35000	02/14/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CARL DAMBKOWSKI 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	05/21/2026	105000	6191367.00

144: Remarks and Signature

Remarks
Date of Notice	06/11/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Carl Dambkowski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)